Skip to content

A comparative study of Trinpanchmula Ghan Vati and Shveta Parpati in the management of Pittaja Mutrakriccha (UTI)

A Randomized Open-labelled comparative clinical study to evaluate the efficacy of Trinpanchmula Ghan Vati with Shveta Parpati in the management of Pittaja Mutrakriccha (UTI) - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070152
Enrollment
60
Registered
2024-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

None listed

Sponsors

Institute For Ayurved Studies and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with age group 18-50 years, irrespective of gender and religion etc. 2. The Patients presented with cardinal features of Pittaja Mutrakriccha such as Daha, Vedana, Peeta mutrata specified in Ayurvedic texts. 3. Patients with laboratory investigations showing either Pus cells/ RBCs/ Epithelial cells in urine sample above normal range is included. 4. Patients willing and able to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients below 18 years and above 50 years. 2. Patients suffering from disease like Diabetes Mellitus, Kidney stone, Benign Prostate Hyperplasia, Cancer, Renal failure, Pyelonephritis, Nephrotic or Nephritic Syndrome, STDs, Sepsis, Tuberculosis, Cardiac disorders etc. 3. Alcohol and other drug abusers. 4. History of trauma. 5. Pregnant and lactating women. 6. Having TLC count more than 12,000 per micro liter

Design outcomes

Primary

MeasureTime frame
The result will be assessed based on improvement in signs and symptoms of Pittaja Mutrakriccha Peeta Mutrata (Yellow color urine), Muhur muhur mutra pravrutti (Frequency of urination), Daha (Burning sensation), Ruja (Pain during urination), Reduction in Total Leucocyte Count (TLC), Reduction in Urine Pus cells, Reduction in Urine RBCTimepoint: 14th day

Secondary

MeasureTime frame
Hb, TLC, DLC, Urine Routine, Color, pH, Specific Gravity, Urine Sugar, Urine Albumin, Urine RBC (Sarakta mutrata), Urine Pus cells, Urine WBC, Urine CultureTimepoint: 14th day

Countries

India

Contacts

Public ContactDr Bharti Yadav

Institute For Ayurved Studies and Research

drlamba.neha@gmail.com09736333868

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026